Court Reopens Teva, Novartis Spat Over Herpes Drug
A U.S. District Court judge has revived Teva Pharmaceutical Industries Ltd.'s case challenging Novartis AG's patents for genital herpes drug Famvir....To view the full article, register now.
Already a subscriber? Click here to view full article